Iridoviruses are a family of large, double-stranded DNA viruses that primarily infect invertebrates, including insects, crustaceans, and amphibians. The name "Iridovirus" is derived from the iridescent appearance of infected tissues under a microscope due to the presence of crystalline arrays of virions. These viruses are classified into two genera: Iridovirus and Chloriridovirus. They possess icosahedral symmetry and exhibit a complex structure with an outer lipid envelope, an icosahedral protein capsid, and an inner core containing the viral genome. Iridovirus infections can have significant ecological and economic implications, particularly in aquaculture, where they can cause mass mortalities in farmed fish and shrimp. The viruses are highly resistant to environmental conditions, contributing to their persistence in aquatic environments. Research on iridoviruses extends beyond their pathogenicity, with investigations into their molecular biology, genome structure, and potential applications in biotechnology. Understanding iridovirus interactions with their hosts is essential for developing strategies to mitigate their impact on aquaculture and ecosystems.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom